Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
This map shows the geographic impact of F M Debruyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F M Debruyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F M Debruyne more than expected).
This network shows the impact of papers produced by F M Debruyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F M Debruyne. The network helps show where F M Debruyne may publish in the future.
Co-authorship network of co-authors of F M Debruyne
This figure shows the co-authorship network connecting the top 25 collaborators of F M Debruyne.
A scholar is included among the top collaborators of F M Debruyne based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F M Debruyne. F M Debruyne is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Kiemeney, Lambertus A., et al.. (1999). Kidney cancer mortality in The Netherlands, 1950-94: prediction of a decreasing trend.. PubMed. 4(4). 303–11.5 indexed citations
2.
Steffens, Martijn G., Jeannette Oosterwijk‐Wakka, Otto C. Boerman, et al.. (1999). Immunohistochemical analysis of tumor antigen saturation following injection of monoclonal antibody G250.. PubMed. 19(2A). 1197–200.21 indexed citations
3.
Poel, H.G. Van Der, M. E. Boon, E. C. M. Ooms, et al.. (1997). Conventional bladder wash cytology performed by four experts versus quantitative image analysis.. PubMed. 10(10). 976–82.18 indexed citations
Vet, Jacqueline A. M., P P Bringuier, H. Ewout Schaafsma, et al.. (1995). Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects.. PubMed. 73(6). 837–43.53 indexed citations
9.
Umbas, Rainy, William B. Isaacs, P P Bringuier, et al.. (1994). Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.. PubMed. 54(14). 3929–33.445 indexed citations
10.
Rosette, Jean J. de la, et al.. (1994). Retreatment rate after surgical and non-surgical treatments.. PubMed. 386. 597–613.4 indexed citations
Tamimi, Yahya, H.G. Van Der Poel, Rainy Umbas, et al.. (1993). Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization.. PubMed. 53(22). 5512–6.118 indexed citations
Boon, M. C., et al.. (1991). Morphometry, densitometry and pattern analysis of plastic-embedded histologic material from urothelial cell carcinoma of the bladder.. PubMed. 13(5). 307–15.15 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.